Disease Severity and Baseline Characteristics of Patients Receiving Mepolizumab or Omalizumab in Employer Claims Database: A real-world experience
Hahn, Beth, Llanos-Ackert, Jean-Pierre, Ortega, Hector, Packnett, Elizabeth, Irwin, Debra, Riehle, Ellen, Chebili, Christina, Bell, ChristopherVolume:
141
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2017.12.033
Date:
February, 2018
File:
PDF, 126 KB
english, 2018